Menu
Back to Journals » Cancer Management and Research » Volume 13
Original Research
Cost-Effectiveness Analysis of Dacomitinib versus Gefitinib in the First-Line Treatment of EGFR-Positive Advanced or Metastatic Non-Small Cell Lung Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,833 | Dovepress* | 3,399+ | 493 | 3,892 | |
| PubMed Central* | 434 | 175 | 609 | ||
| Totals | 3,833 | 668 | 4,501 | ||
| *Since 28 May 2021 | |||||
View citations on PubMed Central and Google Scholar